Evidence map›Paper›PMID 26862262›Full record

ArticleToxicology international

Evaluation of Toxicity Effects of Asafetida on Biochemical, Hematological, and Histological Parameters in Male Wistar Rats.

Seyyed Majid Bagheri, Maryam Yadegari, Aghdas Mirjalily, Mohammd Ebrahim Rezvani

Abstract read
In one paragraph

Article in Toxicology international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Antiviral Effect ofCurrent pharmaceutical biotechnology · 2025
    Review
  2. Nephroprotective Effect ofCurrent pharmaceutical design · 2024
    Article
  3. Review of potential spermatogenic and aphrodisiac effects of the Ferula genus.Clinical and experimental reproductive medicine · 2023
    Article
  4. Anticancer potential ofWorld journal of biological chemistry · 2023
    Review
  5. Article
  6. Preventive Effect ofInternational journal of preventive medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Seyyed Majid BagheriDepartment of Physiology, Herbal Medicine Research Center, Shahid Sadoghi University of Medical Sciences, Yazd, Iran.
Maryam YadegariDepartment of Anatomy, Shahid Sadoghi University of Medical Sciences, Yazd, Iran.
Aghdas MirjalilyDepartment of Anatomy, Shahid Sadoghi University of Medical Sciences, Yazd, Iran.
Mohammd Ebrahim RezvaniNeurobiomedical Research Center, Shahid Sadoghi University of Medical Sciences, Yazd, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAsafetida is traditionally used in folklore medicine for the treatment of various ailments. To validate its use in traditional medicine, it is important to evaluate its toxicity in the animal system. Therefore, this study aimed to evaluate the toxicological effects of asafetida in Wistar albino rats. MATERIALS AND

methodsAcute toxicity tests were conducted by the oral administration of 250, 500, and 1,000 mg/kg body weight of the animal. In chronic study, animals were administered with various doses of asafetida (25, 50, 100, and 200 mg/kg body weight) for a period of 6 weeks. At end of experiment, the effects of asafetida on hematological, renal, and hepatic markers and histological parameters were analyzed.

resultsIn acute toxicity study, no mortality was seen up to 72 h of the administration of asafetida. No signs of neurological and behavioral changes were noticed within 24 h. In the chronic study, the asafetida intake has changed the hematological parameters such as red blood cell (RBC), white blood cell (WBC), hematocrit (HCT), and platelets. Aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) were significantly increased in treated animals. The plasma level of urea and creatinine were not altered by the administration of asafetida throughout the study. Histopathology study indicates hepatotoxicity, but no signs of prominent pathological changes in kidney.

conclusionsAsafetida did not show any acute toxicity, but chronic administration could have undesirable effects on hepatocytes and hematological factors.

Indexed as

Asafetidahematologykidneylivertoxicity

Identifiers

PMID26862262
PMCPMC4721178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.